SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer reports 53% rise in Q2 net profit

05 Nov 2016 Evaluate

Pfizer has reported results for second quarter ended September 30, 2016.   

The company has reported 52.50 % rise in its net profit at Rs 126.33 crore for the quarter under review as compared to Rs 82.84 crore for the same quarter in the previous year. Total income of the company increased by 6.35 % at Rs 581.96 crore for the quarter under review as compared Rs 547.20 crore for the corresponding quarter previous year.   

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

4817.10 -74.50 (-1.52%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×